Where We’re Going

Christian Ethics & Presence in Frontier Technologies


In the next two decades, it is very possible that we will see a Tower of Babel moment as biotechnology and AI/ML converge. Machine learning has demonstrated extraordinary promise in “learning” and imitating the patterns of human language and visual communication, even though it has no understanding of human meaning or intent. It is likely that this capability will be applied to the protein-building instruction codes of life itself—DNA and RNA. If AI can be successfully deployed to introduce arbitrary changes into this instruction set, it may become true of biotechnologists that “nothing they plan to do will be impossible for them.”

As with all techniques, this ability to redesign life, including human life, will inevitably follow some vision of the good and seek to avoid some version of evil. But currently, due in part to the scarcity of Christian presence in biotech, the ethical frameworks that are shaping biotech lack a “theological anthropology” that connects our view of humanity to what is ultimately true and good.

We’re looking for ventures shaped by a Christian vision to accelerate the pipeline of technical and managerial talent into these world-shaping and boundary-pushing fields, increasing the presence of Christian ethics in the rooms where much of the future will be designed. And because any Christian ethic places a priority on the flourishing of the most vulnerable, we are especially interested in ventures that go against the grain of profit-driven markets to protect and promote well-being for the materially poor and those historically neglected by health care technology.


Praxis Ventures

Ventures within the Praxis community working on this ORI.

all ventures
Rare Genomics Institute

makes cutting-edge research technologies of genome sequencing (developed by physicians and scientists around the world) accessible to patients of rare diseases (Jimmy Lin, Nonprofit 2012). Jimmy is also the Chief Scientific Officer at Freenome, which connects people with blood tests for early cancer detection.

Learn More

Partner with Praxis to strengthen our ORIs

Inform and refine our thinking, alert us of ventures working on this ORI, submit your own venture ideas, or send us resources to review.

more ori Content

Stories from the Praxis community.

all content
No items found.

Subscribe for Updates

We will send you announcements, stories, and updates to the ORI list.